Levamisole phosphate is a widely used veterinary medicine that is now being explored for its potential therapeutic benefits in humans. This article will provide an overview of this product, including its chemical properties, health benefits, potential side effects, and dosing information.
Introduction:
Levamisole phosphate is a white or slightly beige crystalline powder that is used as an anthelmintic agent, which means it is used to treat parasitic worms in livestock animals. It was first introduced in the 1960s and has since become one of the most commonly used anthelmintic drugs in the veterinary field. However, more recently, researchers have been exploring its potential therapeutic benefits in humans.
Chemical name:
The chemical name for Levamisole phosphate is (S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole monohydrochloride phosphate.
Molecular formula:
The molecular formula for Levamisole phosphate is C11H12N2S•HCl•H3PO4.
Formula weight:
The formula weight for Levamisole phosphate is 359.8 g/mol.
CAS No:
The CAS No for Levamisole phosphate is 32093-35-9.
Top Ten Google Keywords and Synonyms:
Health Benefits:
Levamisole phosphate has been shown to have both anthelmintic and immune modulating effects. As an anthelmintic, it is used to treat parasitic worm infections in livestock animals. As an immune modulator, it has been studied for its potential therapeutic benefits in humans, particularly in the treatment of certain types of cancer.
The immune modulating effects of Levamisole phosphate are related to its ability to stimulate the immune system's response to cancer cells. It has been shown to increase the number of white blood cells in the body, which can help to fight off infections and cancer cells. It has also been found to increase the activity of natural killer cells and T cells, which are types of white blood cells that play an important role in the body's immune response.
Potential Effects:
The potential therapeutic effects of Levamisole phosphate in cancer treatment have been studied in several clinical trials. One study found that Levamisole phosphate, when combined with other cancer treatments, was effective in increasing the survival rate in patients with stage III colon cancer. Another study found that Levamisole phosphate, when combined with chemotherapy, was effective in reducing the risk of cancer recurrence in patients with stage II and III colon cancer.
In addition to its potential anti-cancer effects, Levamisole phosphate has also been studied for its potential benefits in treating autoimmune diseases, such as rheumatoid arthritis and lupus. It has been found to have immune modulating effects that can help to reduce inflammation and improve symptoms in these conditions.
Product mechanism:
The mechanism by which Levamisole phosphate exerts its immune modulating effects is not yet fully understood. However, it is believed to work by stimulating the immune system's response to cancer cells and other foreign invaders. It has been shown to increase the production of cytokines,
